Table 2.
Prevalence of symptoms in patients and relatives at one-year following intensive care unit treatment for COVID-19.
| Patients (n = 48) | Relatives (n = 42) | |
|---|---|---|
| IES-R scores | ||
| Median (interquartile range) | 21 (8–34) | 46.5 (19–58) |
| IES-R ≥ 18, no (%)§ | 24 (51) | 31 (71) |
| IES-R ≥ 33, no (%)§§ | 12 (25) | 23 (55) |
| Mean IES-R ≥ 1.6 (%)§§§ | 12 (25) | |
| HADS scores | ||
| Anxiety, median (interquartile range) | 7 (3–10) | 10 (7–14) |
| Depression, median (interquartile range) | 4 (2–7) | 5 (2–9) |
| HADS anxiety ≥ 8, no (%)* | 23 (48) | 26 (66) |
| HADS anxiety ≥ 11, no (%)** | 8 (16) | 17 (44) |
| HADS depression ≥ 8, no (%)* | 11 (23) | 13 (33) |
| HADS depression ≥ 11, no (%)** | 6 (13) | 8 (21) |
A score of 8 or more indicating symptoms of anxiety or depression.
A score of 11 or greater indicating definite cases.
A score of 18 or more indicating reactions of clinical importance.
A score of 33 or more indicating severe symptoms with high a probability of a PTSD diagnosis.
A mean score of 1.6 or more indicating a high probability of a PTSD diagnosis.
IES-R, revised impact of event scale; HADS, hospital anxiety and depression scale. Percentages may not sum to 100 owing to rounding. Of the 54 patients included, 47 completed the IES-R, 48 completed the HADS. Of the 42 relatives included, 42 completed the IES-R, 39 completed the HADS.